Sat.Oct 02, 2021 - Fri.Oct 08, 2021

article thumbnail

Pharma is “big business” that uses excuses to keep prices high

World of DTC Marketing

SUMMARY: Americans spend twice as much per capita on drugs as residents of other wealthy nations, because ours is the only country that lets drugmakers set any price they want for their products. Seventy-nine percent of Americans think the price of prescription drugs is “unreasonable,” according to a 2019 Kaiser Family Foundation poll , and about 9 in 10 say they support the idea of the government negotiating prices.

Pharma 241
article thumbnail

Speaking at the 2021 HBA Annual Conference

Authentic Influence Group

The 2021 Healthcare Businesswomen's Association (HBA) Annual Conference this November. #HBAAC21 promises to offer its attendees data-driven and empowering opportunities to: Reimagine pathways to a more equitable and inclusive workplace Build on expanded concepts of advocacy and allyship to engage in mutually beneficial relationships Apply insights from promising and proven practices to champion diversity, equity, and inclusion (DE&I) in their spheres of influence Expand strategies that enhan

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why You’re Not Getting Interviews or Hired

New to Medical Device Sales

You can listen here: [link] You can watch here: [link] Having trouble land an interview? Not getting that offer once you have landed the interview? Today I dive deeper into the top reasons why candidates are getting the results they want! These are the top things I see where candidates could make changes in their process and it would change their outcomes.

article thumbnail

Episode 64 – Riding the Technology Adoption Life Cycle Curve in MedTech with Geoffrey Moore, Author, Crossing the Chasm

Medical Device Success

Reading time: 3 – 5 minutes. This is a special episode. Our guest today is Geoffrey Moore, Author of Crossing The Chasm: Marketing and Selling Disruptive Products to Mainstream Customers which is on Inc. Magazines list of top 10 Marketing Books of All time. He has written several other books on marketing relative to disruptive technologies.

Marketing 130
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

The social media problem for healthcare

World of DTC Marketing

SUMMARY: The Facebook whistleblower lawsuit can be summed up in one sentence: Facebook prioritizes engagement above all else because it leads to more profits even if that engagement containing inflammatory information. Earlier this year, I was asked by a client to write a position paper on using Facebook for the DTC marketing of an oncology product.

Media 224
article thumbnail

Patient Convert Podcast: Effective Non-Verbal Communication Tips in Healthcare

Authentic Influence Group

Some of the loudest things people say don’t come from their mouths. In this Patient Convert Podcast with Justin & Kelly Knott, Shelly shares some fundamental tips to engage with patients, and resources that help physicians refocus and connect better with the patient. Plus: Uncovering the Patterns of Non-Verbal Communication Effective Non-Verbal Communication Tips in Healthcare Using Non-Verbal Communication to Build Trust You don’t want to miss out on gems in this episode >> Tune in

More Trending

article thumbnail

Three Ways Pharma Advertisers Can Benefit from Attention Metrics

Pharma Marketing Network

By: Marc Guldimann, Co-founder and CEO, Adelaide. Targeting and attribution challenges are universal, but pharmaceutical advertisers encounter several unique hurdles with digital advertising. Given their often niche content, pharma marketers must target smaller, more exclusive audiences to drive results while developing impactful creative. Reaching these audiences is further complicated by HIPAA and FTC regulations — not to mention international laws like GDPR and the gradual deprecation of thir

Pharma 98
article thumbnail

Merck gives taxpayers the middle finger

World of DTC Marketing

SUMMARY: Via Axios – The antiviral pill that showed promising results against severe COVID-19 was initially developed at Emory University with $35 million of taxpayer grants. And while it costs $17.74 to produce, according to a report issued last week by drug pricing experts at the Harvard School of Public Health and King’s College Hospital in London.

article thumbnail

5 Ways a Healthcare Marketing Agency Can Help Your Medical Practice

LEVO Health

In the rapidly changing world of healthcare, a healthcare marketing agency is essential to running a successful medical practice. Without a marketing agency, it is extremely difficult to attract new patients or even retain current patients. Fortunately, with a marketing agency tailored specifically towards the healthcare industry, your medical practice may be able to flourish. .

article thumbnail

Forecasting the next moves of a fast-moving pandemic

Clarivate

As the pandemic tore across the world, principal epidemiologist Oliver Blandy knew he had the expertise and data to help fight COVID-19. Get the full story. Oliver Blandy, M.SC Principal Epidemiologist, London, U.K. Hunkered down in London as the COVID-19 pandemic tore across the world in the spring of 2020, Oliver Blandy found himself hoping that he would be tasked with putting his skills to work fighting the virus.

Safety 98
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

How to Get Started in Medical Sales

Axxelus

What does every medical device or pharmaceutical sales team have in common? It isn’t having fancy customer relationship management (CRM) software, continuous education to sharpen skills , and strong leadership. While these are all important for a successful sales department, the one basic thing they all need is skilled and motivated sales representatives to put in the work of selling products and services while building positive relationships with customers.

article thumbnail

Just how bad is Facebook health information? Really bad

World of DTC Marketing

SUMMARY: The health information on Facebook is a danger to anyone who reads it. Experiences from current patients do provide some context but too often contain lousy advice. Facebook should post a warning on every page that deals with health issues that informs people that their physician is still their best source of information. I joined some “private” healthcare condition pages on Facebook and was taken back by the amount of misinformation and bad advice.

Doctors 197
article thumbnail

Four Reasons Rank Order Sales Compensation Plans Cost You Sales

The Marketing Advantage

October 5, 2021 Although rank order plans used to be the most popular type of sales compensation plan utilized throughout the biopharma industry due to their ease of implementation as well as the ability to know the total sales compensation budget in advance, they have increasingly lost favor as they have been proven to not drive sales as well as other types of sales compensation plans, namely goal-based or commission-based plans.

Sales 52
article thumbnail

Improving end-to-end customer experience with Clarivate: treating everyone as your customer

Clarivate

Kerri Nelson , Chief Operations Officer, Clarivate talks about how companies can improve their end-to-end customer experience, treating everyone as a customer. Clarivate implemented a global Customer Delight program in 2019 and a year later acquired CustomersFirst Now, a trusted CX company offering consulting, analytics and software that builds end-to-end Customer Delight programs.

article thumbnail

How to Stay Competitive in the Evolving State of Martech

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

article thumbnail

On the Virtual Road: Sales Tales with Scott Ballenger - Positioning

Zymewire

A few weeks ago, we launched a series of posts here on the Zymewire blog that encapsulate some of my favorite sales parables. In a pre-COVID world, I used to tell these stories to colleagues on the road as a way to encourage us to think differently about how we approach sales and marketing.

Sales 52
article thumbnail

Practical Ways to Improve Work Productivity

Source Explorer

[link].

52
article thumbnail

Infra – Water Report

Curzon Consulting

40
article thumbnail

Electric vehicles hit the road with new gTLDs: Q2 review

Clarivate

Clarivate domain management experts review recent happenings in the domain industry in the Q2 2021 New gTLD Quarterly Report. Read it now. . In our latest analysis of the domain industry, our new gTLD experts take a deep dive into the electric vehicles (EV) market and its crossover into the new gTLD and.brand space. Combining findings from our Top 100 Best Protected Global Brands and The road ahead: Sustainable vehicles today and in the future reports with new analysis, we uncover new insights

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Moderna executives join Forbes richest at taxpayers expense

World of DTC Marketing

SUMMARY: (Times) The financial windfall at Moderna, the biotech company behind one of the three federally cleared Covid-19 vaccines, has propelled three new names onto Forbes magazine’s list of the 400 wealthiest people in the United States. However, it’s the NIH’s vaccine. It is not merely Moderna’s vaccine. Federal scientists helped invent it, and taxpayers are funding its development.

article thumbnail

Top oncology breakthroughs shared at ESMO 2021

Clarivate

Clarivate oncology experts share major takeaways from ESMO and their expected impact on the treatment landscape and patients. As part of our Drugs to Watch series, which reviews therapies expected to have significant impact on healthcare markets, Clarivate oncology experts sifted through the more than 2,800 abstracts that were accepted for presentation at the ESMO 2021 Virtual Conference and selected their top picks.

article thumbnail

Pharmacy benefit reform in Medicaid addresses drug transparency

Clarivate

Clarivate U.S. market access experts discuss recent Medicaid policy changes in some states meant to control drug costs and increase transparency. Read more. In recent years, state governments began to notice rising costs of drugs and hidden charges associated with them. As state and federal governments contribute to a large portion of Medicaid expenses, they are committed to controlling rising Medicaid expenses.